Dr. Scott Michael McClintic, MD

Dr. McClintic practices at Retina Consultants in Salem, Oregon.

Dr. McClintic's NPI, 1033349972, was assigned on July 24, 2009. Dr. McClintic graduated from Ohio State University College of Medicine in 2009. Dr. McClintic holds Oregon license MD167088.

Dr. McClintic's primary practice is Retina Consultants, at 2450 12th SE St, Salem, OR 97302 in Marion County. The practice phone is (503) 371-4350.

Dr. McClintic's primary practice is Retina Consultants in Salem, Oregon. Dr. McClintic is also affiliated with Salem Hospital. The medical group on file is Kaiser Permanente Northwest. Dmand AI also links Dr. McClintic to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McClintic practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. McClintic's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. McClintic is licensed in Oregon.

CMS data shows 33,776 Medicare services from Dr. McClintic across 16 procedure codes in 2024, for 507 Medicare patients. Medicare paid $2,177,469 for them. Every service was in an office.

CMS counts 507 Medicare patients who saw Dr. McClintic in 2024. The largest group is 65 to 74, with 185 patients. 70% of them have high blood pressure, and 60% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McClintic's median patient age at 74, with 58% women.

In 2024, Dr. McClintic wrote 258 Medicare Part D claims for 108 patients. 71% of them were for generic drugs. CMS names the drug for 216 of them, across 8 drugs with 11 or more claims each, at $9,341 in total drug cost. In 2023, CMS named 176 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. McClintic for performance year 2024, reported as part of a group. Dr. McClintic accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 7 papers to Dr. McClintic, published from 2015 to 2021. 2015 was the busiest year, with 2. The most frequent topics are Tomography, Optical Coherence, Choroidal Neovascularization and Fluorescein Angiography. Dr. McClintic has published most often in JAMA Ophthalmol. Dr. McClintic's most frequent co-authors are Steven Theodore Bailey, MD, Christina Joy Flaxel, MD and Kavita V. Bhavsar, MD.

CMS Open Payments shows 29 general payments to Dr. McClintic from 8 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $588.

Dr. McClintic graduated from Ohio State University College of Medicine in 2009.